share_log

144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Dec 19 05:35

Summary by Moomoo AI

Michael Zagorsek, an officer of SoundHound AI, is set to sell 277,813 shares of common stock on 12/18/2024, with an aggregate market value of $5,386,794.07. The shares were acquired through the exercise of stock options on the same date, with cash payment made to the issuer.This transaction follows recent sales by Zagorsek. On 12/16/2024, he sold 138,906 shares for $2,448,773.87, and on 09/20/2024, he sold 42,001 shares for $204,943.88. In total, Zagorsek has sold 180,907 shares in the past three months, generating gross proceeds of $2,653,717.75.The planned sale is part of a pre-arranged trading plan adopted on 03/19/2024, demonstrating a structured approach to the officer's stock transactions. This series of sales suggests a significant reduction in Zagorsek's holdings in SoundHound AI, potentially impacting investor perception of insider confidence in the company.
Michael Zagorsek, an officer of SoundHound AI, is set to sell 277,813 shares of common stock on 12/18/2024, with an aggregate market value of $5,386,794.07. The shares were acquired through the exercise of stock options on the same date, with cash payment made to the issuer.This transaction follows recent sales by Zagorsek. On 12/16/2024, he sold 138,906 shares for $2,448,773.87, and on 09/20/2024, he sold 42,001 shares for $204,943.88. In total, Zagorsek has sold 180,907 shares in the past three months, generating gross proceeds of $2,653,717.75.The planned sale is part of a pre-arranged trading plan adopted on 03/19/2024, demonstrating a structured approach to the officer's stock transactions. This series of sales suggests a significant reduction in Zagorsek's holdings in SoundHound AI, potentially impacting investor perception of insider confidence in the company.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more